Molbio Diagnostics shares jump 5% as HDFC MF buys 1.99% stake via bulk deal | Newly listed stock up 71% from IPO price
HDFC Bank pursued an acquisition in an ipo & listings development with October 1 in focus.
· LiveMint Markets
Molbio Diagnostics shares rose over 5% on October 1, after HDFC Mutual Fund acquired a 1.99% stake. The stock gained approximately 71% since its IPO, and Jefferies assigned a ‘Buy’ rating, setting a target price of ₹1,600, indicating over 98% upside potential.
Key facts
- Dates in focus
- October 1
The analysis
HDFC Bank reported ₹1,600,, with movement of 5%, 71% and 98% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is -1.5% on the day at ₹692.20, and has returned -14.6% over three months. It sits 31% below its 52-week high, which means a good deal of bad news was already in the price. The banks sector has moved -1.7% over the same period, so HDFC Bank is running 12.9 points behind its peers.
This is a Promoter stake / pledge event. Promoters transact with better information than the market. Direction against the price trend is the signal — accumulation into weakness reads differently from a sale into strength. On the day the stock is -1.5%, so a modest reaction.
Why it matters
- Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
- Fund flows and NAV moves show where domestic retail conviction is actually going, month after month.
- Sustained FII or DII direction moves the whole market, not just the names being bought — it sets the tape's tone.
Market context
- The company directly in focus is HDFCBANK.
- Sector exposure: Banks.
- The immediate tone of coverage reads positive.
In this story
Related coverage
Anup Bagchi vs Sashidhar Jagdishan: How HDFC Bank’s incoming CEO pay compares with his predecessor
Shadowfax Technologies shares jump 137% from IPO price; ICICI Securities sees 15% upside | Should you buy?
Rs 13,000 crore blow in September! Why Indian financial stocks are fastest to sell for FIIs this year
Banks vs NBFCs: Which stocks could benefit as RBI set to hike rates for the first time in 3 years?
FPIs sell Rs 21,745 crore in second half of Sep, in oil & gas, auto & financials